Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Gaviscon Advance is a reflux suppressant medication for the relief of heartburn and acid indigestion (dyspepsia), including symptoms such as burning in the chest, bloating, sour taste in the mouth, and difficulty swallowing. It is suitable for use during pregnancy and breastfeeding. The product forms a protective layer that floats on top of stomach contents to prevent reflux into the esophagus. Its active ingredients are sodium alginate and potassium hydrogen carbonate (potassium bicarbonate). The mechanism of action involves both antacid effects to neutralize excess stomach acid and alginate raft formation to physically block reflux.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on gaviscon advance.